Chemoinformaics analysis of 8ALPHA-8-HYDROXY-12-OXO-13-ABIETEN-18-OIC ACID
Molecular Weight | 334.456 | nRot | 2 |
Heavy Atom Molecular Weight | 304.216 | nRig | 18 |
Exact Molecular Weight | 334.214 | nRing | 3 |
Solubility: LogS | -3.879 | nHRing | 0 |
Solubility: LogP | 2.797 | No. of Aliphatic Rings | 3 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 56.6118 |
nHD | 2 | BPOL | 31.8322 |
QED | 0.809 |
Synth | 4.474 |
Natural Product Likeliness | 2.603 |
NR-PPAR-gamma | 0.583 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.018 |
Pgp-sub | 0 |
HIA | 0.007 |
CACO-2 | -5.099 |
MDCK | 0.0000202 |
BBB | 0.716 |
PPB | 0.904673 |
VDSS | 0.406 |
FU | 0.120788 |
CYP1A2-inh | 0.011 |
CYP1A2-sub | 0.83 |
CYP2c19-inh | 0.022 |
CYP2c19-sub | 0.768 |
CYP2c9-inh | 0.082 |
CYP2c9-sub | 0.406 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.12 |
CYP3a4-inh | 0.078 |
CYP3a4-sub | 0.177 |
CL | 1.135 |
T12 | 0.427 |
hERG | 0.007 |
Ames | 0.042 |
ROA | 0.263 |
SkinSen | 0.11 |
Carcinogencity | 0.355 |
EI | 0.416 |
Respiratory | 0.942 |
NR-Aromatase | 0.493 |
Antiviral | Yes |
Prediction | 0.648145 |